Statins inhibit endogenous cholesterol production by competitive inhibition of HMG-CoA reductase (HMGCR), the enzyme that catalyzes conversion of HMG-CoA to mevalonate, an early rate-limiting step in cholesterol synthesis. This pathway delineates genes involved in statin pharmacogenomics, including genes involved in mediating the effects of statins on plasma lipoprotein metabolism.
Revision 96008 of this pathway is featured in a Wikipedia article as an interactive map.
Review changes for Featured
Revision 137242 of this pathway was tagged to be featured on the front page of WikiPathways by Egon Willighagen.
Ontology Terms
Saving...
No Tags!
Pathway Ontology :
Disease :
Cell Type :
Bibliography
Chen H, Ikeda U, Shimpo M, Shimada K; ''Direct effects of statins on cells primarily involved in atherosclerosis.''; Hypertens Res, 2000 PubMedEurope PMCScholia
Wetterau JR, Lin MC, Jamil H; ''Microsomal triglyceride transfer protein.''; Biochim Biophys Acta, 1997 PubMedEurope PMCScholia